IL-33/ST2 promotes the malignant progression of gastric cancer via the MAPK pathway

Gastric cancer (GC) remains one of the commonest malignant tumors and the second leading cause of cancer-related deaths worldwide. IL-33 is highly expressed in tumor tissues and serum of patients with GC. However, the function of the IL-33 and IL-33 receptor ST2 in the malignant progression of GC is...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ning, Cui, Xing, Li, Wen, Zhang, Chunlai, Liu, Liqing, Li, Jinxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985998/
https://www.ncbi.nlm.nih.gov/pubmed/33760194
http://dx.doi.org/10.3892/mmr.2021.12000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985998/
https://www.ncbi.nlm.nih.gov/pubmed/33760194
http://dx.doi.org/10.3892/mmr.2021.12000

Ejemplares similares